Build an opioid stewardship program that protects patients and ensures compliance
Opioid management is a complex responsibility for hospital pharmacists. Medication errors involving high-risk drugs, particularly opioids, can lead to adverse drug events, patient harm, and increased liability. At the same time, maintaining compliance with The Joint Commission standards, state regulations, and Board of Pharmacy requirements is resource-intensive and prone to audit risk. With only 41% of hospitals operating an active opioid stewardship program (OSP), many organizations lack the real-time visibility and standardized processes needed to identify risk before it reaches the patient.
Sentri7 Opioid Stewardship addresses these challenges by using evidence-based rules and clinically maintained algorithms to deliver real-time patient-specific milligram equivalent (MME) calculations, which help pharmacists pinpoint opportunities to optimize medication selection, dose, and course of action. It surfaces high-risk patients proactively, so pharmacy teams can act quickly, promote multi-modal therapies, and reduce the likelihood of opioid-related adverse events, all within their existing clinical workflow.
The result is a measurable improvement in both compliance and patient outcomes. Health systems can view opioid use, prescribing patterns, and interventions across the enterprise to support governance and demonstrate alignment with Joint Commission expectations for safe opioid prescribing. By documenting each clinical intervention, pharmacy leaders can also quantify their impact and reinforce a culture of safety.